A detailed history of Freemont Management S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Freemont Management S.A. holds 6,400 shares of VRTX stock, worth $3.22 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
6,400
Previous 6,400 -0.0%
Holding current value
$3.22 Million
Previous $3 Million 0.77%
% of portfolio
1.56%
Previous 1.68%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$392.81 - $485.53 $12.3 Million - $15.2 Million
-31,300 Reduced 83.02%
6,400 $3 Million
Q1 2024

May 13, 2024

SELL
$407.69 - $446.08 $4.77 Million - $5.22 Million
-11,700 Reduced 23.68%
37,700 $15.8 Million
Q3 2023

Nov 09, 2023

SELL
$338.18 - $362.46 $2.81 Million - $3.01 Million
-8,300 Reduced 14.38%
49,400 $17.2 Million
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $4.92 Million - $5.53 Million
17,200 Added 42.47%
57,700 $16.7 Million
Q3 2022

Nov 07, 2022

BUY
$273.83 - $305.53 $5.39 Million - $6.02 Million
19,700 Added 94.71%
40,500 $11.7 Million
Q2 2022

Jul 29, 2022

SELL
$234.96 - $292.55 $281,952 - $351,060
-1,200 Reduced 5.45%
20,800 $5.86 Million
Q1 2022

May 06, 2022

SELL
$221.42 - $260.97 $2.21 Million - $2.61 Million
-10,000 Reduced 31.25%
22,000 $5.74 Million
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $6.62 Million - $8.83 Million
32,000 New
32,000 $7.56 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Freemont Management S.A. Portfolio

Follow Freemont Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freemont Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Freemont Management S.A. with notifications on news.